Can Fite Biofarma Ltd (CANF)
1.92
-0.02
(-1.03%)
USD |
NYAM |
Apr 25, 16:00
1.93
+0.01
(+0.52%)
After-Hours: 20:00
Can Fite Biofarma Price to Book Value: 1.535 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 1.535 |
| April 24, 2024 | 1.551 |
| April 23, 2024 | 1.575 |
| April 22, 2024 | 1.583 |
| April 19, 2024 | 1.583 |
| April 18, 2024 | 1.575 |
| April 17, 2024 | 1.567 |
| April 16, 2024 | 1.663 |
| April 15, 2024 | 1.655 |
| April 12, 2024 | 1.679 |
| April 11, 2024 | 1.822 |
| April 10, 2024 | 1.878 |
| April 09, 2024 | 1.807 |
| April 08, 2024 | 1.918 |
| April 05, 2024 | 1.878 |
| April 04, 2024 | 1.862 |
| April 03, 2024 | 1.830 |
| April 02, 2024 | 1.795 |
| April 01, 2024 | 1.846 |
| March 28, 2024 | 1.775 |
| March 27, 2024 | 1.641 |
| March 26, 2024 | 1.583 |
| March 25, 2024 | 1.590 |
| March 22, 2024 | 1.619 |
| March 21, 2024 | 1.590 |
| Date | Value |
|---|---|
| March 20, 2024 | 1.619 |
| March 19, 2024 | 1.583 |
| March 18, 2024 | 1.590 |
| March 15, 2024 | 1.539 |
| March 14, 2024 | 1.554 |
| March 13, 2024 | 1.626 |
| March 12, 2024 | 1.554 |
| March 11, 2024 | 1.634 |
| March 08, 2024 | 1.605 |
| March 07, 2024 | 1.568 |
| March 06, 2024 | 1.546 |
| March 05, 2024 | 1.525 |
| March 04, 2024 | 1.554 |
| March 01, 2024 | 1.546 |
| February 29, 2024 | 1.554 |
| February 28, 2024 | 1.510 |
| February 27, 2024 | 1.525 |
| February 26, 2024 | 1.525 |
| February 23, 2024 | 1.496 |
| February 22, 2024 | 1.525 |
| February 21, 2024 | 1.488 |
| February 20, 2024 | 1.503 |
| February 16, 2024 | 1.508 |
| February 15, 2024 | 1.525 |
| February 14, 2024 | 1.481 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7884
Minimum
Apr 12 2023
12.29
Maximum
Jun 29 2020
3.260
Average
2.580
Median
Nov 30 2021
Price to Book Value Benchmarks
| Compugen Ltd | 2.595 |
| Pluri Inc | 5.822 |
| BioLine Rx Ltd | 3.478 |
| XTL Biopharmaceuticals Ltd | 5.229 |
| BiomX Inc | 6.022 |
Price to Book Value Related Metrics
| PS Ratio | 11.01 |
| Price | 1.92 |
| Earnings Yield | -156.2% |
| Market Cap | 9.582M |